Risk factors for intracerebral hemorrhage differ according to hemorrhage location

Neurology

Volumn 79, Issue 23, 2012, Pages 2275-2282

  Martini, Sharyl R ^a   Flaherty, Matthew L ^a   Brown, W Mark ^a   Haverbusch, Mary ^c   Comeau, Mary E ^c   Sauerbeck, Laura R ^a   Kissela, Brett M ^c   Deka, Ranjan ^b   Kleindorfer, Dawn O ^a   Moomaw, Charles J ^a   Broderick, Joseph P ^a   Langefeld, Carl D ^c   Woo, Daniel ^a  

^a Division of Neurology   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; WARFARIN;

ACADEMIC ACHIEVEMENT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GENOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LOBAR INTRACEREBRAL HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NONLOBAR INTRACEREBRAL HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 84871302997     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318276896f     Document Type: Article

References (38)

1. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage: a powerful and easyto-use predictor of 30-day mortality. Stroke 1993;24:987-993.
2. Hemphill JC III, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001;32:891-897.
3. Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 2004;164:880-884.
4. Sacco S, Marini C, Toni D, Olivieri L, Carolei A. Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. Stroke 2009;40:394-399.
5. Rost NS, Smith EE, Chang Y, et al. Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke 2008;39:2304-2309.
6. Schwarz S, Hafner K, Aschoff A, Schwab S. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology 2000;54:354-361.
7. Woo D, Sauerbeck LR, Kissela BM, et al. Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke 2002; 33:1190-1195.
8. Zia E, Pessah-Rasmussen H, Khan FA, et al. Risk factors for primary intracerebral hemorrhage: a population-based nested case-control study. Cerebrovasc Dis 2006;21:18-25.
9. Labovitz DL, Halim A, Boden-Albala B, Hauser WA, Sacco RL. The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics. Neurology 2005;65:518-522.
10. Biffi A, Sonni A, Anderson CD, et al. Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol 2010;68:934-943.
11. Flaherty ML, Woo D, Haverbusch M, et al. Racial variations in location and risk of intracerebral hemorrhage. Stroke 2005;36:934-937.
12. Woo D, Kaushal R, Chakraborty R, et al. Association of apolipoprotein e4 and haplotypes of the apolipoprotein E gene with lobar intracerebral hemorrhage. Stroke 2005;36: 1874-1879.
13. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993;11:575-580.
14. Zhao CX, Cui YH, Fan Q, et al. Small dense low-density lipoproteins and associated risk factors in patients with stroke. Cerebrovasc Dis 2009;27:99-104.
15. Sturgeon JD, Folsom AR, Longstreth WT Jr, Shahar E, Rosamond WD, Cushman M. Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke 2007;38: 2718-2725.
16. O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010;376:112-123.
17. Wieberdink RG, Poels MM, Vernooij MW, et al. Serum lipid levels and the risk of intracerebral hemorrhage: the Rotterdam study. Arterioscler Thromb Vasc Biol 2011;31: 2982-2989.
18. Konishi M, Iso H, Komachi Y, et al. Associations of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteries: The Akita pathology study. Stroke 1993;24:954-964.
19. Amarenco P, Bogousslavsky J, Callahan A III, et al. Highdose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-559.
20. Garcia C, Pinho e Melo T, Rocha L, Lechner MC. Cerebral hemorrhage and APOE. J Neurol 1999;246:830-834.
21. Viswanathan A, Greenberg S. Cerebral amyloid angiopathy in the elderly. Ann Neurol 2011;70:871-880.
22. Peck G, Smeeth L, Whittaker J, Casas JP, Hingorani A, Sharma P. The genetics of primary haemorrhagic stroke, subarachnoid haemorrhage and ruptured intracranial aneurysms in adults. PLoS One 2008;3:e3691.
23. O'Donnell HC, Rosand J, Knudsen KA, et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 2000;342:240-245.
24. Tzourio C, Arima H, Harrap S, et al. APOE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology 2008;70:1322-1328.
25. Seifert T, Lechner A, Flooh E, Schmidt H, Schmidt R, Fazekas F. Lack of association of lobar intracerebral hemorrhage with apolipoprotein e genotype in an unselected population. Cerebrovasc Dis 2006;21:266-270.
26. Flaherty ML, Haverbusch M, Sekar P, et al. Location and outcome of anticoagulant-associated intracerebral hemorrhage. Neurocrit Care 2006;5:197-201.
27. Flaherty ML. Anticoagulant-associated intracerebral hemorrhage. Semin Neurol 2010;30:565-572.
28. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994;343:687-691.
29. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASAK study. Lancet 1989;333:175-179.
30. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-1151.
31. Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365:981-992.
32. Qureshi AI, Suri MF, Saad M, Hopkins LN. Educational attainment and risk of stroke and myocardial infarction. Med Sci Monit 2003;9:CR466-473.
33. Kleindorfer DO, Lindsell C, Broderick J, et al. Impact of socioeconomic status on stroke incidence: a populationbased study. Ann Neurol 2006;60:480-484.
34. Broderick JP, Bonomo JB, Kissela BM, et al. Withdrawal of antithrombotic agents and its impact on ischemic stroke occurrence. Stroke 2011;42:2509-2514.
35. Kleindorfer DO, Khoury J, Moomaw CJ, et al. Stroke incidence is decreasing in whites but not in blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati/Northern Kentucky Stroke Study. Stroke 2010;41:1326-1331.
36. Natarajan S, Lipsitz SR, Nietert PJ. Self-report of high cholesterol: determinants of validity in US adults. Am J Prev Med 2002;23:13-21.
37. Vargas CM, Burt VL, Gillum RF, Pamuk ER. Validity of selfreported hypertension in the National Health and Nutrition Examination Survey III, 1988-1991. Prev Med 1997;26:678-685.
38. Bonevski B, Campbell E, Sanson-Fisher RW. The validity and reliability of an interactive computer tobacco and alcohol use survey in general practice. Addict Behav 2010;35:492-498.